Start:
January 2010
End:
July 2014
Enrollment:
360
This study will examine the impact of receiving a genetic risk assessment for Alzheimer's disease among individuals with mild cognitive impairment (MCI).
Minimum Age: 55 Years
Maximum Age: 90 Years
++Amnestic mild cognitive impairment (as defined by the Petersen criteria)++Fluent in English++Close friend, relative, or spouse willing to attend each study visit with the participant and complete surveys and interviews
++Current untreated anxiety or depression++Diagnosis of dementia or Alzheimer's disease
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Lead: Brigham and Women's Hospital
Collaborator Sponsor
Source: ClinicalTrials.gov ID: NCT01434667
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health